ERBB2 and myoepithelial tumor: For benign salivary gland tumors, results reporting the rate of HER2/neu overexpression in myoepithelioma had no statistically significant publication bias (p=0.060), and studies assessing the expression rate of HER2/neu in pleomorphic adenomas had a statistically significant publication bias (p=0.06).